Vertex Pharmaceuticals Lays Off 140 Staff Following Diabetes Asset Axing
SOURCENews reportView the filing ↗
What we know
Based on news reporting.
Summary
Vertex Pharmaceuticals Incorporated has laid off 140 employees after deciding to discontinue its diabetes asset. This decision reflects a strategic shift within the company as it focuses on other areas of its business. The layoffs are part of a broader restructuring effort aimed at optimizing operations and reallocating resources. While specific details about the affected locations or departments were not disclosed, this move indicates the company's commitment to streamline its workforce in response to changing market conditions.
Vertex Pharmaceuticals Incorporated cut 140 jobs as of June 11, 2025.
That is roughly 2.6% of the 5,400 people Vertex Pharmaceuticals Incorporated employs.
LayoffTalk has tracked 3 layoff events at Vertex Pharmaceuticals Incorporated since June 2025, with 3 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Vertex Pharmaceuticals Incorporated
Recent tracked events at this company.